Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Corvus Pharmaceuticals, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 300K | Dec 20, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CRVS | Corvus Pharmaceuticals, Inc. | Dec 20, 2024 | 1 | $0 | 4 | Dec 23, 2024 | Chief Financial Officer |
CRVS | Corvus Pharmaceuticals, Inc. | Dec 6, 2023 | 1 | $0 | 4 | Dec 8, 2023 | Chief Financial Officer |
CRVS | Corvus Pharmaceuticals, Inc. | Dec 13, 2022 | 2 | $25.6K | 4 | Dec 15, 2022 | Chief Financial Officer |
CRVS | Corvus Pharmaceuticals, Inc. | Aug 11, 2022 | 1 | $0 | 4 | Aug 15, 2022 | Chief Financial Officer |
CRVS | Corvus Pharmaceuticals, Inc. | Mar 16, 2022 | 2 | $77K | 4 | Mar 17, 2022 | Chief Financial Officer |
CRVS | Corvus Pharmaceuticals, Inc. | Sep 9, 2021 | 1 | $0 | 4 | Sep 13, 2021 | Chief Financial Officer |